novo nordisk glp-1 patent litigation Compounding Crackdown How to Survive the GLP-1

Key Takeaway Can you take BPC-157 with GLP-1 medications

doi: 10.3389/fonc.2023.1168321 32

The severity of these effects depends on the dose and duration of treatment

Written by Scott McDonald Paramedic and Chief Strategic Officer, Clinical Educator at Iowa IV Reviewed by Jake Sanchez MSN, FNP-BC, FNP-C, CCRN and Medical Director of Iowa IV Need hydration support during weight loss

10.1126/science.aaf2693 Science 232 ZhangJ.WangH

Inhibit osteoclast activation and differentiation, reduce bone resorption Block osteoclast differentiation signal RANKL/RANK/OPG pathway: AOD 9604 downregulates the expression of RANKL (a key factor in osteoclast differentiation) and upregulates the expression of OPG (a RANKL antagonist), reducing the RANKL/OPG ratio by 50-60% and blocking the differentiation of osteoclast precursors into mature osteoclasts